REQUEST A DEMO
Total
USD $0.00
Search more companies

Alventa Pharma Limited (India)

Main Activities: All Other Chemical Product and Preparation Manufacturing
Full name: Alventa Pharma Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alventa Pharma Limited is an unlisted company, incorporated on 28/10/2016. It has its registered office in the State of West Bengal, India. Company's corporate identification number (CIN) is U24299WB2016PLC225674 and registration number is 225674. The company is a manufacturing, trade company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading.

Legal Address
Room No.79 & 80, 3Rd Floorat 55, Biplabi Rash Behari Basu Road (Mehta Building)
Kolkata; West Bengal; Postal Code: 700001

Contact Details: Purchase the Alventa Pharma Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Alventa Pharma Limited report to view the information.
Registered Capital:
Purchase the Alventa Pharma Limited report to view the information.
Incorporation Date:
October 28, 2016
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Nominee Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
85.74%
Company Performance
Financial values in the chart are available after Alventa Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
57.95%
Total operating revenue
53.21%
Operating profit (EBIT)
114%
EBITDA
113.54%
Net Profit (Loss) for the Period
114.76%
Total assets
60.88%
Total equity
754.96%
Operating Profit Margin (ROS)
0.66%
Net Profit Margin
0.5%
Return on Equity (ROE)
-54.34%
Debt to Equity Ratio
-58.86%
Quick Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?